RSS Feeds by Section
Small Mutations Identified through Deep DNA Sequencing for AML and MDS
Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These...
9-Dec-2019 5:05 PM EST
Add to Favorites
Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery
Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported...
9-Dec-2019 4:20 PM EST
Add to Favorites
Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider
A Rutgers Cancer Institute of New Jersey investigator and other collaborators examined prenatal screening practices for blood disorders between different types of care providers and found different variations in prenatal guidance.
5-Dec-2019 9:00 AM EST
Add to Favorites
Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission
Rutgers Cancer Institute of New Jersey investigators compared outcomes for allogeneic stem cell transplant patients when post-transplant cyclophosphamide (PCy) was added as part of standard treatment than if standard treatment was given alone....
5-Dec-2019 8:45 AM EST
Add to Favorites
Rutgers Cancer Institute Researchers Identify Novel Gene Associated with Prognosis in Aggressive form of Ovarian Cancer
Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool.
5-Dec-2019 8:00 AM EST
Add to Favorites
Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma
In what is believed to be one of the largest studies of a rare disorder known as primary cutaneous gamma delta T-cell lymphoma, Rutgers Cancer Institute
investigators and other collaborators examined characteristics, treatment patterns and...
4-Dec-2019 8:00 AM EST
Add to Favorites
$250K Grant Supports Exploration of Tumor Microenvironment in Lung Cancer
The GO2 Foundation for Lung Cancer has awarded $250,000 to investigators at Rutgers Cancer Institute of New Jersey and Princeton University toward the identification and development of novel strategies to address treatment resistance in non-small...
3-Dec-2019 1:00 PM EST
Add to Favorites
Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment
Gene expression profiling and other analyses conducted by Rutgers Cancer Institute of New Jersey researchers and colleagues examining drug resistance to a common antibody therapy for non-Hodgkin lymphoma have identified calcium signaling as a novel...
2-Dec-2019 2:35 PM EST
Add to Favorites
see all news
Oncology Pharmacists: An Essential Partner in the Cancer Journey
One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey...
18-Oct-2019 8:00 AM EDT
Lumpectomy for Breast Cancer with Attention to Cosmetic Results
As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.
25-Sep-2019 2:05 PM EDT
Leukemia: Not Just One Disease
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
30-Aug-2019 8:05 AM EDT
Colorectal Cancer: Advancing Awareness
Colorectal cancer is the third leading cancer in both new cases and cancer deaths in the United States. While colorectal cancer incidence declined 3.7 percent annually from 2006 to 2015 for those 55 and older, rates have increased 1.8 percent...
18-Mar-2019 3:05 PM EDT
A New Tool to Help Fight an Old Enemy – Lung Cancer
In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT
September is Sickle Cell Disease Awareness Month
Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT
Thyroid Cancer 101
While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the
butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT
Ovarian Cancer: What You Need to Know
During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT
